41 research outputs found

    Failure phenomena in carbon/epoxy microcomposite model systems

    Get PDF

    Failure phenomena in two-dimensional multi-fibre microcomposites, Part 2: A Raman spectroscopic study into the influence of inter-fibre spacing on stress concentrations

    Get PDF
    Raman spectroscopy is used to determine the influence of inter-fibre spacing on the stress concentration factor (SCF) resulting from a fibre break in a two-dimensional (2-D) carbon/epoxy microcomposite. Microcomposites with an inter-fibre spacing varying from 0.8–19.0 fibre diameters (f) have been investigated. The SCF was found to decrease from a value of 1.26 at an inter-fibre spacing of 0.8f to a value of 1.06 at an inter-fibre spacing of 10.4f. The experimentally found variation of SCF with inter-fibre spacing was compared to some analytical models available in the literature. It was found that none of the models is able to describe the experimental data adequately. The effect of the SCF on the failure process is also discussed. At relatively small inter-fibre spacings the SCF is sufficiently high to cause further fibre failure in neighbouring fibres resulting in alignment of fibre breaks. At increasing inter-fibre spacing the decrease in SCF results in a decreasing influence of the initial fibre break on the progressive fibre failure process and the failure process becomes more random

    Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort

    Get PDF
    BACKGROUND: C3 glomerulopathy (C3G) is a rare kidney disorder characterized by predominant glomerular depositions of complement C3. C3G can be subdivided into dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). This study describes the long-term follow-up with extensive complement analysis of 29 Dutch children with C3G. METHODS: Twenty-nine C3G patients (19 DDD, 10 C3GN) diagnosed between 1992 and 2014 were included. Clinical and laboratory findings were collected at presentation and during follow-up. Specialized assays were used to detect rare variants in complement genes and measure complement-directed autoantibodies and biomarkers in blood. RESULTS: DDD patients presented with lower estimated glomerular filtration rate (eGFR). C3 nephritic factors (C3NeFs) were detected in 20 patients and remained detectable over time despite immunosuppressive treatment. At presentation, low serum C3 levels were detected in 84% of all patients. During follow-up, in about 50% of patients, all of them C3NeF-positive, C3 levels remained low. Linear mixed model analysis showed that C3GN patients had higher soluble C5b-9 (sC5b-9) and lower properdin levels compared to DDD patients. With a median follow-up of 52 months, an overall benign outcome was observed with only six patients with eGFR below 90 ml/min/1.73 m(2) at last follow-up. CONCLUSIONS: We extensively described clinical and laboratory findings including complement features of an exclusively pediatric C3G cohort. Outcome was relatively benign, persistent low C3 correlated with C3NeF presence, and C3GN was associated with higher sC5b-9 and lower properdin levels. Prospective studies are needed to further elucidate the pathogenic mechanisms underlying C3G and guide personalized medicine with complement therapeutics. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-021-05221-6

    A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats

    Get PDF
    A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. After immunization of mice with partially-purified heparan sulfate proteoglycan (HSPG) isolated from rat glomeruli, a monoclonal antibody (mAb JM-403) was obtained, which was directed against heparan sulfate (HS), the glycosaminoglycan side chain of HSPG. In ELISA it reacted with isolated human glomerular basement membrane (GBM) HSPG, HS and hyaluronic acid, but not with the core protein of human GBM HSPG, and not with chondroitin sulfate A and C, dermatan sulfate, keratan sulfate and heparin. Furthermore, it did not bind to laminin, collagen type IV or fibronectin. Specificity of JM-403 for HS was also suggested by results of inhibition studies, which found that intact HSPG and HS, but not the core protein, inhibited the binding of JM-403 to HS. In indirect immunofluorescence on cryostat sections of rat kidney, a fine granular to linear staining of the GBM was observed, along with a variable staining of the other renal basement membranes. Pretreatment of the sections with heparitinase completely prevented the binding of mAb JM-403, whereas pretreatment with chondroitinase ABC or hyaluronidase had no effect. The precise binding site of mAb JM-403 was investigated by indirect immunoelec-tron microscopy. It revealed a diffuse staining of the whole width of the GBM. One hour after intravenous injection of JM-403 into rats, the mAb was detected along the glomerular capillary wall in a fine granular pattern, which shifted towards a more mesangial localization after 24 hours. No binding was observed anymore by day 15. Intravenous injection induced a dose-dependent, transient and selective proteinuria that was maximal immediately after the injection. Administration of 2 mg of JM-403 increased the urinary albumin excretion within the first 24 hours after injection from (mean ± SD) 177 ± 19 to 20,755 ± 10,310 µg/24 hr (P < 0.01); the urinary IgG excretion increased from 5.8 ± 2.9 to 236.1 ± 132.2 µg/24 hr (P < 0.03); the selectivity index (clearance IgG/clearance albumin) decreased from 0.33 ± 0.12 to 0.12 ± 0.05 (P < 0.004)

    An experimental and numerical investigation into failure phenomena in multi-fibre microcomposites

    No full text

    Failure phenomena in carbon/epoxy microcomposite model systems

    No full text

    An experimental and numerical investigation into the single-fibre fragmentation test : stress transfer by a locally yielding matrix

    Get PDF
    Single-fibre fragmentation tests on carbon/epoxy microcomposites were performed using carbon fibres with surface treatment levels varying from 0 to 200% of the commercial fibre surface treatment, i.e. 100%. Polarized light microscopy showed substantial local matrix yielding near the fibre-matrix interface in the case of good fibre-matrix adhesion. The level of fibre surface treatment proved to have a large influence on both the final fragment length distribution and the debonded length. The experimental fragment length distributions were compared to predicted fragment length distributions resulting from a numerical simulation of the fibre fragmentation test, based on stress transfer through a yielding matrix and frictional shear stress. Good agreement between the experimental results and the predictions was observed for the case of little debonding. Because of the observed stress transfer through a locally yielding matrix, the classical stress transfer theories for the fibre fragmentation test do not determine a realistic value for the strength of the fibre-matrix interface
    corecore